- $1.88bn
- $1.62bn
- $771.32m
- 77
- 26
- 79
- 63
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 41.72 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 5.52 | ||
Price to Tang. Book | 5.52 | ||
Price to Free Cashflow | 54.04 | ||
Price to Sales | 2.43 | ||
EV to EBITDA | 102.94 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -5.51% | ||
Return on Equity | -6.35% | ||
Operating Margin | -3.9% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 393.72 | 540.8 | 598.11 | 669.76 | 771.32 | 883.86 | 1,004.86 | 15.8% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +46.6 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company offers holistic vision care by selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. It sells a range of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. Its customers can customize their prescription lenses with a variety of options, including single-vision, progressive, light-responsive, blue-light-filtering, and non-prescription lenses. It also offers in-house technologies like Virtual Vision Test and Virtual Try-On to enhance the overall customer experience. It sells its own brand of contacts, Scout by Warby Parker, and third-party contact lenses; this allows it to provide customers with a vision care offering. Its Website and mobile app make it easy for its customers to browse, virtually try on, and purchase glasses.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 7th, 2009
- Public Since
- September 29th, 2021
- No. of Shareholders
- 15
- No. of Employees
- 2,218
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange
- Shares in Issue
- 120,858,809

- Address
- 233 Spring Street, 6Th Floor East, NEW YORK, 10013
- Web
- https://www.warbyparker.com/
- Phone
- +1 6468477215
- Auditors
- Ernst & Young LLP
Latest News for WRBY
Upcoming Events for WRBY
Q1 2025 Warby Parker Inc Earnings Call
Q1 2025 Warby Parker Inc Earnings Release
Warby Parker Inc Annual Shareholders Meeting
Q2 2025 Warby Parker Inc Earnings Release
Similar to WRBY
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
As of Today at 24:03 UTC, shares in Warby Parker are trading at $15.52. This share price information is delayed by 15 minutes.
Shares in Warby Parker last closed at $15.52 and the price had moved by +21.73% over the past 365 days. In terms of relative price strength the Warby Parker share price has outperformed the S&P500 Index by +12.36% over the past year.
The overall consensus recommendation for Warby Parker is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWarby Parker does not currently pay a dividend.
Warby Parker does not currently pay a dividend.
Warby Parker does not currently pay a dividend.
To buy shares in Warby Parker you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $15.52, shares in Warby Parker had a market capitalisation of $1.88bn.
Here are the trading details for Warby Parker:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: WRBY
Based on an overall assessment of its quality, value and momentum Warby Parker is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Warby Parker is $23.50. That is 51.42% above the last closing price of $15.52.
Analysts covering Warby Parker currently have a consensus Earnings Per Share (EPS) forecast of $0.32 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Warby Parker. Over the past six months, its share price has underperformed the S&P500 Index by -4.45%.
As of the last closing price of $15.52, shares in Warby Parker were trading -20.11% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Warby Parker PE ratio based on its reported earnings over the past 12 months is 41.72. The shares last closed at $15.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Warby Parker's management team is headed by:
- Neil Blumenthal - CFD
- David Gilboa - CFD
- Lee Fixel - DRC
- Andrew Hunt - DRC
- Jeffrey Raider - DRC